In a White House speech, President Joe Biden announced that the cancer moonshot program, which he spearheaded during the Obama administration, is getting ready for another takeoff.
The addition of oxaliplatin does not extend progression-free survival in elderly patients with metastatic colorectal cancer and in fact, can lead to more severe adverse events.